TSS
QNCX icon

Two Sigma Securities’s Quince Therapeutics QNCX Stock Holding History

Two Sigma Securities’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-60
Closed -$19.8K – 1890
2025
Q2 		$19.8K Buy
+60
New +$13.7K ﹤0.01% 1210
2024
Q1 		– Sell
-60
Closed -$12.6K – 3525
2023
Q4 		$12.6K Buy
+60
New +$12K ﹤0.01% 2791
2022
Q1 		– Sell
-69
Closed -$174K – 2431
2021
Q4 		$174K Buy
+69
New +$421K 0.01% 1104

Other funds holding QNCX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Two Sigma Securities's QNCX Position: Q3 2025 in Review

Two Sigma Securities sold out of Quince Therapeutics (QNCX) in Q3 2025, closing a stake of 60 shares — an estimated $19.8K sold.

Two Sigma Securities first reported a position in QNCX in Q4 2021 and held it in 3 quarters. The position peaked at $174K in Q4 2021. 41 funds tracked by Wall St. Rank hold QNCX as of Q3 2025.

  • Two Sigma Securities reported no remaining Quince Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 60 Quince Therapeutics shares in Q3 2025, an estimated $19.8K.
  • Two Sigma Securities first reported a position in Quince Therapeutics in Q4 2021 and held it in 3 quarters.
  • Two Sigma Securities's Quince Therapeutics position peaked at $174K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held Quince Therapeutics as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.